Consolidated Balance Sheets (Unaudited) (USD $)	Jun. 30, 2014	Sep. 30, 2013
CURRENT ASSETS
Cash	$ 99,054	$ 116,714
Prepaid Expenses	15,000	15,000
Note Receivable	2,222	0
Interest Receivable	14	0
Total Current Assets	116,290	131,714
OTHER ASSETS
Deposits	4,200	4,200
Deferred Financing Costs	0	65,000
Available for Sale Securities	5,000	7,000
Total Other Assets	9,200	76,200
TOTAL ASSETS	125,490	207,914
CURRENT LIABILITIES
Accounts Payable	144,474	138,572
Notes Payable	383,731	219,372
Bank Overdraft	0	0
Accrued Payroll	547,094	612,094
Accrued Payroll Taxes	49,887	45,386
Accrued Interest	262,747	239,829
Accrued Expenses	5,000	5,000
Convertible Note Payable Net of Unamortized Discount	97,701	98,701
Due to Affiliate	0	34,895
Current portion, note payable to affiliated party	1,000	1,000
Due to Shareholder	100,000
Total Current Liabilities	1,591,634	1,394,849
Total Liabilities	1,591,634	1,394,849
STOCKHOLDERS EQUITY (DEFICIT)
Preferred Stock ($0.0001 par value) 20,000,000 shares authorized; 2,063,821 issued and outstanding as of September 30, 2013 and June 30, 2014	207	207
Series AA Preferred ($0.0001 par value) 100,000 shares authorized; 94,852 issued and outstanding as of September 30, 2013 and June 30, 2014	9	9
Series AAA Preferred ($0.0001 par value) 1,000,000 shares authorized 40,000 shares issued and outstanding as of September 30, 2013 and June 30, 2014	4	4
Series B Preferred Shares ($0.0001 par value) 2,000,000 shares authorized; 725,409 issued and outstanding as of September 30, 2013 and June 30, 2014 respectively	73	73
Common Stock ($0.0001 par value) 5,000,000,000 shares authorized; 2,390,304,145 and 2,951,045,145 issued and outstanding as of September 30, 2013 and June 30, 2014 respectively	295,099	239,029
Non Voting Convertible Preferred Stock ($1 Par value) 200,000 shares authorized; 0 shares issued and outstanding as of September 30, 2013 and June 30, 2014
Additional Paid in capital	16,167,486	14,845,671
Contributed Capital	509,355	509,355
Retained Earnings (Deficit) accumulated during the development stage	22,845,424	24,542,314
Accumulated Other Comprehensive Income (Loss)	(41,331,361)	(41,329,361)
Total Stockholders' Equity (Deficit) Biomatrix Scientific Group, Inc.	(1,513,704)	(1,192,699)
Noncontrolling Interest in subsidiary	47,560	5,765
Total Stockholders' Equity	(1,466,144)	(1,186,934)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	$ 125,490	$ 207,914